A key reason for joining TOPRA is to network with other regulatory professionals from all over the world. We provide opportunities to exchange news, views and ideas face-to-face and online, formally and informally. Our ever-expanding collection of communities groups is segmented by region and topic.

* * Now online * *

Our new and improved Communities platform is now available for use.

Take me there


'TOPRA In' regional groups

'TOPRA In' groups support regulatory professionals living and working in a country or region, providing a forum for discussion and networking.

The groups aim to:

  • Develop a local TOPRA networking arm in individual countries for meetings and discussion
  • Support the TOPRA members living and working in a country and increase the membership of regulatory professionals
  • Work cooperatively with other not-for-profit or government organisations and relevant academic institutions. 

TOPRA In groups worldwide
Current groups

  • Austria
  • Benelux
  • Central & Eastern Europe
  • England & Wales
  • France
  • Germany
  • India
  • Ireland
  • Italy
  • North America
  • Scotland
  • Spain
  • Sweden
  • Switzerland

Get involved

More 'TOPRA In' groups are currently being developed. To find out more or to get involved with setting up a group, email our membership team.

Upcoming TOPRA In community events

Start dateTitleDescriptionCityCountry
28/10/2021TOPRA In Scotland - Clinical TrialsThis TOPRA in Scotland meeting will be held via webinar, and will include presentations on the supply of comparators and other licensed medicines for clinical trials, and the pros and cons of blinding in clinical trials, with time for a Q&A session. OnlineSCOOCT21
29/10/2021Regulatory Framework for COVID vaccine development in IndiaTOPRA in INDIA steering group invites to you to join this Member Webinar focussing on the Regulatory framework for COVID vaccine development in India with guest speaker, Varma Bhupathiraju. OnlineTI10
16/11/2021TOPRA In Sweden - Medical Devices: New Regulations for IVDRThis evening is an ideal opportunity to discuss the new In Vitro Diagnostic Medical Devices Regulation (IVDR), which will be fully implemented from 26 May 2022. Background and EU Commission perspective. How is the work at the Medical Products Agency affected and how do the companies prepare? What applies to clinical performance studies on IVD products? OnlineSWENOV21
17/11/2021TOPRA In CEE-Herbal Medicinal Products Regulatory LandscapePlease join Alenka Drazumeric from our TOPRA In Central Eastern Europe network who will present this informative webinar covering an  'Overview of Herbal Medicinal Products Regulatory Landscape in Europe'. OnlineCEE21
19/11/2021TOPRA In India - Roles and Limitation of AIThis TOPRA In India webinar will explore the roles and limitations of Artificial Intelligence in Regulatory Intelligence in this informative session with guest speaker Dharmesh Kharwar– Founder and Director at NGB Laboratories Ltd. OnlineTII11


Special Interest Networks (SPINs)

TOPRA's Special Interest Networks:

  • Promote contact between regulatory professionals working in the same specialist sector
  • Provide a forum for exchanging views and ideas and for mutual support
  • Ensure that the needs of these sectors are taken into account in the TOPRA training programme and to encourage expert input into the content of courses
  • Encourage contributions to Regulatory Rapporteur on specialist topics.
SPIN Networks graphic

Current SPINs:

  • Biotechnology
  • Chemistry, Manufacturing and Controls (CMC)
  • Clinical Trials
  • Medical Technologies (MedTech)
  • New Regulatory Professionals
  • Pharmacovigilance
  • Product Information and Labelling
  • Regulatory Intelligence
  • Regulatory Operations (formerly the eRA SPIN)
  • Veterinary Regulatory Affairs

New Patient Engagement SPIN!

How patient engagement operates in the drug and medical devices development lifecycle with a view to increasing further involvement. The Patient Engagement SPIN considers ways to incorporate the patient voice early and consistently as a clinical programme evolves. It is a source of best practice for applying patient engagement insights and learnings in regulatory work. 

Upcoming Special Interest Network (SPIN) events

Start dateTitleDescription
27/10/2021Biotech SPIN Webinar: Risk Based Approach To ATMPsFollowing on from the successful webinar on the Clinical Development on ATMPs on 7 April, Dr Bridget Heelan returns with a follow up presentation.BIOOCT21